CDX2 and colorectal carcinoma: Accordingly, the meta-analysis conducted by Touvier et al. (2011) did not observe significant associations between FokI, PolyA, TaqI, Cdx2, and ApaI VDR polymorphisms and CRC risk, although the BsmI polymorphism was associated with a lower CRC risk [48].